Journal
LEUKEMIA & LYMPHOMA
Volume 56, Issue 6, Pages 1793-1798Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/10428194.2014.966707
Keywords
Tumor necrosis factor-alpha; TNF; interferon-gamma; IFNG; polymorphisms; aplastic anemia
Categories
Funding
- Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)
- Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)
- Fundacion A. J. Roemmers
Ask authors/readers for more resources
The impaired hematopoiesis in acquired aplastic anemia (AA) results from immune-mediated mechanisms. We characterized polymorphisms implicated in controlling type-1 cytokine production in 69 patients with AA. Our data suggest that the studied polymorphisms are not associated with susceptibility in the overall AA population. However, the presence of the higher expressing TNF - 308A allele was associated with younger age (p = 0.0297) and more profound neutropenia (p = 0.0312), and over-represented in patients with very severe AA (p = 0.0168). The higher producing IFNG 12 CA-repeat allele showed strong linkage disequilibrium with the + 8741 allele, and was associated with a lower hemoglobin level (p = 0.0351). Also, the presence of at least one higher expressing variant was more frequent among patients responding to immunosuppressive treatment (p = 0.0519). Our findings suggest that the presence of higher expressing variants of tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) in AA patient genotypes could be related to clinical parameters, disease severity and therapy outcomes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available